As of 3:59pm ET
| -0.08 / -5.16%|
The 1 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +36.05% increase from the last price of 1.47.
The current consensus among 2 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.